July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee BPC-157, KPV, TB-500, and MOTs-C bulk drug substances
Tirzepatide produced 20.2% weight loss versus 13.7% for semaglutide at 72 weeks and has stronger body-composition results. Semaglutide has the longer safety history, cardiovascular outcomes data, kidney outcomes data, and an oral formulation. Oral semaglutide What about oral semaglutide (Rybelsus)
It is particularly effective against damage caused by alcohol, stress, and chronic NSAID use
Mouse research suggests that NNMT inhibition can change energy use inside cells, and an eight-week study in aged mice found better grip strength
NNMT inhibitor studied in metabolic research
However, the study had no control group and several methodological issues, so the results should be viewed with caution